MARC21

000	03471nam 2200409zi 4500
001	9.932280
003	CaOODSP
005	20240131144420
006	m o d f
007	cr mn\|\|\|\|\|\|\|\|\|
008	240110e20180201onca ob f000 0 eng d
040	\|aCaOODSP\|beng\|erda\|cCaOODSP
043	\|an-cn---
045	\|ay0y1
086	1 \|aH14-512/2018E-PDF
245	00\|aEvaluation of the Health Canada Canadian Blood Services contribution programs 2013-14 to 2016-17 : \|bfinal report / \|cOffice of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.
246	17\|aEvaluation of the Health Canada Canadian Blood Services contribution programs 2013-2014 to 2016-2017
264	1\|a[Ottawa] : \|bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, \|cFebruary 1, 2018.
300	\|a1 online resource (xiii, 55 pages) : \|bcolour illustration
336	\|atext\|btxt\|2rdacontent
337	\|acomputer\|bc\|2rdamedia
338	\|aonline resource\|bcr\|2rdacarrier
500	\|aIssued also in French under title: Évaluation des programmes de la Société canadienne du sang bénéficiaires de contributions de Santé Canada 2013-2014 à 2016-2017 : rapport final.
500	\|aCover title.
504	\|aIncludes bibliographical references (pages 54-55).
520	\|a"The purpose of this evaluation was to assess the relevance and performance (effectiveness, efficiency and economy) of the Health Canada Canadian Blood Services (CBS) Contribution Programs, which include the Organ and Tissue Donation and Transplantation (OTDT) Program, and the Blood Research and Development (R&D) Program. The evaluation focused on the period from 2013-14 to 2016-17, and updated findings from the previous evaluation, which covered the period from 2008-09 to 2012-13. The evaluation was undertaken in accordance with the requirements of the Financial Administration Act and the Treasury Board Policy on Results (2016). Through the OTDT Program, Health Canada funds CBS for activities relating to national governance, development of leading clinical practices, system performance improvement, and public education and awareness. Through the Blood R&D Program, Health Canada funds CBS to undertake R&D activities to improve the safety and supply of the Canadian blood system"--Executive summary, page iv.
610	20\|aCanadian Blood Services\|xFinance\|xEvaluation.
650	0\|aDonation of organs, tissues, etc.\|xGovernment policy\|zCanada\|xEvaluation.
650	0\|aTransplantation of organs, tissues, etc.\|xGovernment policy\|zCanada\|xEvaluation.
650	0\|aBlood banks\|xGovernment policy\|zCanada\|xEvaluation.
650	0\|aBlood\|xTransfusion\|xGovernment policy\|zCanada\|xEvaluation.
710	1 \|aCanada. \|bHealth Canada. \|bOffice of Audit and Evaluation, \|eissuing body.
710	2 \|aPublic Health Agency of Canada. \|bOffice of Audit and Evaluation, \|eissuing body.
775	08\|tÉvaluation des programmes de la Société canadienne du sang bénéficiaires de contributions de Santé Canada 2013-2014 à 2016-2017 : \|w(CaOODSP)9.933213
856	40\|qPDF\|s538 KB\|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-512-2018-eng.pdf
856	4 \|qHTML\|sN/A\|uhttps://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/evaluation-health-canada-canadian-blood-services-contributon-programs-2013-14-2016-17.html